TearClear Appoints Dr. Amir Shojaei Chief Development Officer
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, a global ophthalmic pharmaceutical company, has announced the appointment of Amir Shojaei, Pharm.D., Ph.D., as chief development officer, a major step towards planning and executing multiple clinical development and registration programs. Over his 23-year career, Dr. Shojaei has focused on the clinical development, […]
UF Startup TearClear Appoints Robert J. Dempsey as CEO
UF startup TearClear, a global Ophthalmic Pharmaceutical Company, announced the appointment of Robert J. Dempsey as Chief Executive Officer. TearClear, a resident client at UF Innovate | Sid Martin Biotech, is the only pharmaceutical company to administer preservative-free eye drops to the ocular surface, that are preserved safely prior to dosing. Dempsey, who has more […]